Skip to content

This Site is Intended for Healthcare Professionals Only

Search AI Powered

Latest Stories

VIEWPOINT: Beyond the pandemic

Lung health expert Dr Alison Cook commends community pharmacy teams for providing a ‘lifeline’ for people living with various lung conditions…

For too long, people with lung conditions have seen a lack of progress in their treatment, diagnosis, and care. We know that one in five people will develop a lung condition in their lifetime, but respiratory disease continues to be an area where things are not improving fast enough to support the millions of people who need help.


In fact, every year, lung conditions account for 700,000 hospital admissions, and outcomes for lung disease have not improved in over a decade.

This is where community pharmacy comes in.

More than 1.6 million people visit a community pharmacy each day, and our local chemists can offer a wide range of services for people with lung disease. From ordering and collecting prescriptions to flu vaccinations, stop smoking services and inhaler technique checks, the potential of our local pharmacists to support people living with lung disease has never been clearer.

When the Taskforce for Lung Health-a collaboration of more than 30 different respiratory bodies, patients, charities and organisations looking to improve lung health in England – surveyed over 2,000 people with lung conditions on how they use their local pharmacies, we discovered that 95 per cent of people living with lung disease who use community pharmacies found the services they accessed valuable and essential, or something they ‘could not live without’.

This, alongside our wider findings, highlights just how much untapped potential our local pharmacies hold.

Lung Lung conditions account for 700,000 hospital admissions every year

Raising awareness

People with lung conditions taking part in the Taskforce survey reflected on the fact that community pharmacy is often much easier to access than other forms of routine care.

According to our survey, three quarters (75 per cent) of people with lung disease who use community pharmacies value their services because they are close to home. Other reasons for valuing the service were convenient opening times (39 per cent), not requiring an appointment (48 per cent) and finding local chemists easier to access than a GP appointment (26 per cent).

But despite the strong understanding of the vital role pharmacies could play in their care, our survey found that people with lung conditions who use community pharmacies were unaware of, or not using crucial services which have the potential to drastically improve their wellbeing.

According to our findings, one in four people (23 per cent) were not aware of the full range of services available in community pharmacies. To ease the pressures faced by the NHS in the pandemic and beyond, it is important to raise awareness of the variety of services community pharmacies offer, encourage more people with lung conditions to make better use of community pharmacy services overall, and expand the range the range of services offered.

For example, inhaler technique checks are a crucial part of basic care for people with lung disease but are often missed or not carried out properly. Poor inhaler technique or incorrect use of inhalers can potentially risk life-threatening exacerbations or asthma attacks.

With nearly half (48 per cent) not using this service, and a quarter of those not using it saying they were unaware it was available, we think that there is a real opportunity to make this service more accessible and improve its uptake among people with lung disease.

Flu jabs are another vital service which community pharmacies offer. However, only one in four respondents (23 per cent) used the service. This suggests that increased uptake of the flu jab in local pharmacies could alleviate winter pressures on hospitals and the NHS as a whole.

Rebuilding trust

Perhaps unsurprisingly, our survey also showed that the pandemic has meant that more than a third of people with lung conditions (37 per cent), began to use pharmacies less than before, due to anxieties about catching the virus.

However, despite this, the majority of respondents stated that they would feel safer using the services if they believed the appropriate measures (e.g. social distancing), had been put in place.

Confidence in the safety of local pharmacies needs to be restored among users with lung conditions in the coming months, to ensure that they continue to play a crucial role in supporting people with lung disease.

People with lung conditions recognize the importance of community pharmacy as a lifeline for their care, but there is clearly still work to do in making the wide variety of services available known to everyone.

Whether it’s flu jabs or inhaler technique checks, the level of untapped resource available at our fingertips to support people with lung conditions and the NHS has never been clearer.

By far the most important change we need to see is an investment into integrating our pharmacies into NHS care pathways. Our local pharmacies play an important role in protecting people with lung conditions, and there are endless benefits to creating a more integrated system of care where people with lung conditions are made aware of, and feel encouraged to access vital services at their local pharmacy.

We have already seen the monumental impact local pharmacies can have with their crucial role in the Covid-19 vaccination effort-it is now vital that everyone is made aware of the wide variety of services pharmacies offer, and that further integration of local pharmacies into the NHS becomes a priority. This would not only better meet the needs of people with lung disease, but also reduce the pressures faced by the NHS during the pandemic and for years to come.

Dr Alison Cook is chair of the Taskforce for Lung Health.

More For You

fungal test for fatal infections

The test detects the disease within 30 minutes

Getty Images

New fungal test may save people from fatal infections

Key Summary

  • The University of Exeter has developed a prototype test that detects mucormycosis (black fungus) in 30 minutes
  • The test promises timely treatment and could reach hospitals within three years, pending regulatory approval
  • Mucormycosis surged after Covid-19 in India, causing 3,500 deaths in 2021, mainly affecting those with weak immunity

  • The University of Exeter is developing a new test which could detect a fatal fungal infection before patients reach a critical stage.

    Mucormycosis – black fungus disease, is a common yet potentially dangerous disease that rose post the second wave of the Covid-19 pandemic.

    Keep ReadingShow less
    Inhaled insulin injection for children at mealtime

    The inhaled formula did not have any adverse effects on patients’ lungs, the researchers reported.

    Pic credit: iStock

    Inhaled insulin as good as injection for children at mealtime

    Children with diabetes who inhaled their mealtime doses of insulin did just as well as those who injected insulin under the skin, researchers reported at the American Diabetes Association scientific meeting in Chicago.

    To regulate their blood sugar, patients with type 1 diabetes usually require an injection of a long-acting basal insulin once a day, plus additional injections of rapid-acting insulins at mealtimes.

    Keep ReadingShow less
    PDA calls for action on disability and ethnicity pay gap reporting

    A disabled pharmacy employee at work

    Getty Images

    PDA calls for action on disability and ethnicity pay gap reporting

    Key Summary
    • PDA backs mandatory disability and ethnicity pay gap reporting for large employers
    • Reports and research show ethnic minority locums earn 10% less, with wider pay disparities
    • PDA urges action plans and annual data to address inequality and boost inclusivity

    The Pharmacists’ Defence Association (PDA) has come forward in support of the proposal seeking proper monitoring and reporting of ethnicity and disability pay gaps by employers with more than 250 staff.

    Employers of this nature already monitor and report for gender pay gaps.

    Keep ReadingShow less
    Cancer risk warning on alcohol bottles

    Medical and health organisations want bottles and cans of beer, wine and spirits to carry cancer risk labels.

    iStock

    Health groups want alcohol labels to carry cancer risk warning

    Key Summary

    • The campaigners want “bold and unambiguous” labels stating the link between drinking and cancer
    • They claim that alcohol is proven to increase the risk of breast, bowel, stomach, head, neck, liver and mouth cancer
    • The alcohol industry claims labels may create “unnecessary anxiety”

    Dozens of medical and health organisations have jointly written to prime minister Keir Starmer that bottles and cans of beer, wine and spirits should have labels that state the link between drinking and cancer.

    Keep ReadingShow less
    There is ‘no clear path to the sustainable funding’ for community pharmacy, says Rebecca Smith MP

    Rebecca Smith MP (second from right) and Esi Kumurdzi (third from right) at Tubb Pharmacy

    There is ‘no clear path to the sustainable funding’ for community pharmacy, says Rebecca Smith MP

    Rebecca Smith MP made an impassioned plea to the government to invest in community pharmacy after explaining the vital role her local pharmacy plays supporting residents in two villages.

    Addressing the health and social care select committee on Tuesday (23), Smith, the Conservative MP for South West Devon, said community pharmacy needed ‘sustainable funding’ and reflected on the plight of her local pharmacy.

    Keep ReadingShow less